Protective Effects of Memantine, an NMDA Receptor Antagonist, Against Cerebral Ischemia/Reperfusion Induced Injuries in Rats with Transient Congenital Hypothyroidism Neuroprotective effects of memantine in hypothyroidism
Iranian Journal of Pharmaceutical Sciences,
Vol. 18 No. 2 (2022),
1 April 2022
,
Page 138-147
https://doi.org/10.22037/ijps.v18.42141
Abstract
Stroke is one of the major causes of mortality worldwide. Memantine, an NMDA receptor antagonist, has protective effects on neuronal cells and is important candidate as a neuroprotective agent in cerebral ischemia. On the other hand, thyroid hormones are one of the important factors in the development of the central nervous system (CNS) and its activity and the long-term adverse effects of transient thyroid function abnormalities at birth on intellectual development has been proven. Therefore, the aim of the present study was to evaluate the effects of memantine on cerebral ischemia/reperfusion (I/R) induced injuries in transient congenital hypothyroidism (TCH). The adult male Wistar TCH rats (240±20 g) were underwent forebrain ischemia by bilateral common carotid artery occlusion for 17 min. Memantine (20 mg/kg) alone or in combination with vitamin C (200 mg/kg) were administered intraperitoneally (ip) for 7 days after cerebral ischemia. Then, histopathology, cerebral infarct size and malondialdehyde level were evaluated. Histopathological analysis showed that memantine significantly decreased leukocyte infiltration in comparison to I/R group (p<0.01). Memantine also reduced infarct size and malondialdehyde level compared with I/R group (p<0.01). Memantine and vitamin C combination group had no significant effects on leukocyte infiltration, infarct size and malondialdehyde level. Our results showed that memantine through reduction in leukocyte infiltration, lipid peroxidation and infarct size could reduce cerebral ischemia/reperfusion induced injuries in transient congenital hypothyroidism. Hence, memantine might be considered as a neuroprotective agent in hypothyroidism.
- Brain ischemia, Cerebral infarction, Hypothyroidism, Inflammation, Memantine, Oxidative stress.
How to Cite
References
[2] Islambulchilar SK, M. Sattari, H. Ayramlo, M. Evaluation of the changes in plasma concentrations of few free amino acids in ischemic and non-ischemic stroke patients. Res Pharm Sci. (2012) 7 (5): 145.
[3] Prabhakaran S, Naidech Andrew M. Ischemic Brain Injury After Intracerebral Hemorrhage. Stroke (2012) 43 (8):2258-2263.
[4] Karimipour M, Shojaei Zarghani S, Mohajer Milani M, Soraya H. Pre-Treatment with Metformin in Comparison with Post-Treatment Reduces Cerebral Ischemia Reperfusion Induced Injuries in Rats. Bull Emerg Trauma (2018) 6 (2):115-121.
[5] Wang F, Liang W, Lei C, Kinden R, Sang H, Xie Y, et al. Combination of HBO and Memantine in Focal Cerebral Ischemia: Is There a Synergistic Effect? Mol Neurobiol (2015) 52 (3):1458-66.
[6] Abd-Elsameea AA, Moustaf AA, Mohamed AM. Modulation of the oxidative stress by metformin in the cerebrum of rats exposed to global cerebral ischemia and ischemia/reperfusion. Eur Rev Med Pharmacol Sci (2014) 18 (16):2387-92.
[7] Gong G, Xiang L, Yuan L, Hu L, Wu W, Cai L, et al. Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats. Plos One (2014) 9 (3):e89450.
[8] Babu CS, Ramanathan M. Pre-ischemic treatment with memantine reversed the neurochemical and behavioural parameters but not energy metabolites in middle cerebral artery occluded rats. Pharmacol Biochem Behav (2009) 92 (3):424-32.
[9] Kilic U, Yilmaz B, Reiter RJ, Yüksel A, Kilic E. Effects of memantine and melatonin on signal transduction pathways vascular leakage and brain injury after focal cerebral ischemia in mice. Neuroscience (2013) 237:268-76.
[10] Mayor D, Tymianski M. Neurotransmitters in the mediation of cerebral ischemic injury. Neuropharmacology (2018) 134:178-88.
[11] Lipton SA. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx (2004) 1 (1):101-10.
[12] Shaki F, Shayeste Y, Karami M, Akbari E, Rezaei M, Ataee R. The effect of epicatechin on oxidative stress and mitochondrial damage induced by homocycteine using isolated rat hippocampus mitochondria. Res Pharm Sci (2017) 12 (2):9.
[13] Thomas SJ, Grossberg GT. Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias. Clin Interv Aging (2009) 4:367-77.
[14] Robinson DM, Keating GM. Memantine: a review of its use in Alzheimer's disease. Drugs (2006) 66 (11):1515-34.
[15] Liu C, Lin N, Wu B, Qiu Y. Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury. Brain Res (2009) 1282:173-82.
[16] Varshosaz J, Taymouri S, Pardakhty A, Asadi-Shekaari M, Babaee A. Niosomes of Ascorbic Acid and ?-Tocopherol in the Cerebral Ischemia-Reperfusion Model in Male Rats. Biomed Res Int (2014) 2014:816103.
[17] May JM. Vitamin C transport and its role in the central nervous system. Subcell Biochem (2012) 56:85-103.
[18] Lagowska-Lenard M, Stelmasiak Z, Bartosik-Psujek H. Influence of vitamin C on markers of oxidative stress in the earliest period of ischemic stroke. Pharmacol Rep (2010) 62 (4):751-6.
[19] Alva-Sánchez C, Becerril A, Anguiano B, Aceves C, Pacheco-Rosado J. Participation of NMDA-glutamatergic receptors in hippocampal neuronal damage caused by adult-onset hypothyroidism. Neurosci Lett (2009) 453 (3).
[20] Yi J, Zheng JY, Zhang W, Wang S, Yang ZF, Dou KF. Decreased pain threshold and enhanced synaptic transmission in the anterior cingulate cortex of experimental hypothyroidism mice. Mol Pain (2014) 10 (38).
[21] Ozdemir H, Akman I, Coskun S, Demirel U, Turan S, Bereket A, et al. Maternal thyroid dysfunction and neonatal thyroid problems. Int J Endocrinol (2013) 2013.
[22] Shafiee SM, Vafaei AA, Rashidy-Pour A. Effects of maternal hypothyroidism during pregnancy on learning, memory and hippocampal BDNF in rat pups: Beneficial effects of exercise. Neuroscience (2016) 329:151-61.
[23] Derafshpour L, Saboory E, Vafaei AA, Rashidy-Pour A, Roshan-Milani S, Rasmi Y, et al. Interactive Effects of Exercise, Sex Hormones, and Transient Congenital Hypothyroidism on Long-Term Potentiation in Hippocampal Slices of Rat Offspring. Basic Clin Neurosci (2019) 10 (2):119-36.
[24] Cattani D, Goulart PB, Cavalli VL, Winkelmann-Duarte E, Dos Santos AQ, Pierozan P, et al. Congenital hypothyroidism alters the oxidative status, enzyme activities and morphological parameters in the hippocampus of developing rats. Mol Cell Endocrinol (2013) 375 (1-2):14-26.
[25] Akbari A, Jelodar G, Nazifi S. Vitamin C Protects Rat Cerebellum and Encephalon from Oxidative Stress Following Exposure to Radiofrequency Wave Generated by BTS Antenna Model. Toxicol Mech Method (2014).
[26] Soraya H, Rameshrad M, Mokarizadeh A, Garjani A Metformin attenuates myocardial remodeling and neutrophil recruitment after myocardial infarction in rat. Bioimpacts (2015) 5 (1):3-8.
[27] Arslan E, Gel MS, Demir S, Arslan EA, Koşucu M, Karahan SC. The Effects of Rifampicin on Experimental Cerebral Ischemia/Reperfusion Injury in Rats. Iran Red Crescent Med J (2019) 21 (8):e87869.
[28] Kamat PK, Kalani A, Metreveli N, Tyagi SC, Tyagi N. A possible molecular mechanism of hearing loss during cerebral ischemia in mice. Can J Physiol Pharmacol (2015) 93 (7):505-16.
[29] Dhawan J, Benveniste H, Luo Z, Nawrocky M, Smith SD, Biegon A. A new look at glutamate and ischemia: NMDA agonist improves long-term functional outcome in a rat model of stroke. Future Neurol (2011) 6 (6):823-34.
[30] Talhada D, Santos CRA, Gonçalves I, Ruscher K. Thyroid Hormones in the Brain and Their Impact in Recovery Mechanisms After Stroke. Front Neurol (2019) 10:1103-.
[31] Rastogi L, Godbole M, Ray M, Rathore P, Pradhan S, Gupta S, et al. Reduction in oxidative stress and cell death explains hypothyroidism-induced neuroprotection subsequent to ischemia/reperfusion insult. Exp. Neurol (2006) 200:290-300.
[32] Lai TW, Shyu WC, Wang YT. Stroke intervention pathways: NMDA eceptors and beyond. Trends Mol Med (2011) 17 (5):266-75.
[33] Wu QJ, Tymianski M. Targeting NMDA receptors in stroke: new hope in neuroprotection. Mol Brain (2018) 11:15.
[34] Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci (2001) 69 (4):369-81.
[35] Jander S, Schroeter M, Stoll G. Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia.
J Neuroimmunol (2000) 109 (2):181-7.
[36] Görgülü A KT, Cobanoglu S, Unal F, Izgi NI, Yanik B, Küçük M. Reduction of edema and infarction by Memantine and MK-801 after focal cerebral ischaemia and reperfusion in rat. Acta Neurochir (Wien) (2000) 142 (11):1287-92.
[37] Aluclu M, Arslan S, Acar A, Guzel A, Bahceci S, Yaldiz M. Evaluation of effects of memantine on cerebral ischemia in rats. Neurosciences (Riyadh) (2008) 13 (2):113-6.
[38] Ozsüer H, Görgülü A, Kiriş T, Cobanoğlu S. The effects of memantine on lipid peroxidation following closed-head trauma in rats. Neurosurg Rev (2005) 28 (2):143-7.
[39] Sil S, Ghosh T, Ghosh R. NMDA receptor is involved in neuroinflammation in intracerebroventricular colchicine-injected rats.
J Immunotoxicol (2016) 13 (4):474-89.
[40] Ghasemi M, Phillips C, Fahimi A, McNerney MW, Salehi A. Mechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders. Neurosci Biobehav Rev (2017) 80:555-72.
[41] Wu Q, Zhao Y, Chen X, Zhu M, Miao C. Propofol attenuates BV2 microglia inflammation via NMDA receptor inhibition. Can J Physiol Pharmacol (2018) 96 (3):241-8.
[42] Wu HM, Tzeng NS, Qian L, Wei SJ, Hu X, Chen SH et al. Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation. Neuropsychopharmacology (2009) 34 (10):2344-57.
[43] Sandstrom MI, Rebec GV. Extracellular ascorbate modulates glutamate dynamics: role of behavioral activation. BMC Neurosci (2007) 8:32.
[44] Domith I, Socodato R, Portugal CC, Munis AF, Duarte-Silva AT, Paes-de-Carvalho R. Vitamin C modulates glutamate transport and NMDA receptor function in the retina. J Neurochem (2018) 144 (4):408-20.
- Abstract Viewed: 56 times
- IJPS-Vol18- Issue 2-page 138-147 Downloaded: 28 times